(Q34842494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

John P Pierce

1 reference

ORCID Public Data File 2021

author name string

L Madlensky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

L Natarajan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

S Tchu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

M Pu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

S W Flatt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

D M Nikoloff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

G Hillman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

M R Fontecha

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

H J Lawrence

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

B A Parker

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

A H B Wu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

J P Pierce

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

23 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

718-725

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients

26 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

Genotype-guided tamoxifen therapy: time to pause for reflection?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

Time-varying effects of prognostic factors associated with disease-free survival in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

CYP2D6 genotyping and the pharmacogenetics of tamoxifen

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

Tamoxifen, hot flashes and recurrence in breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

Selective serotonin-reuptake inhibitors for the treatment of hot flashes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

Metabolites of tamoxifen in animals and man: Identification, pharmacology, and significance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081375

Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen

8 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.32

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.32

The Impact of CYP2D6 Genotyping on Tamoxifen Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.32

Evidence and practice regarding the role for CYP2D6 inhibition in decisions about tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.32

A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.32

Resampling and cross-validation techniques: a tool to reduce bias caused by model building?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.32

Tamoxifen, soy, and lifestyle factors in Asian American women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.32

A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.32

Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.32

Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study

21 January 2018

1 reference

12 December 2020

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

1 reference

12 December 2020

Estrogen receptors and distinct patterns of breast cancer relapse

1 reference

12 December 2020

Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment

1 reference

12 December 2020

Identification of 4-hydroxy-N-desmethyltamoxifen as a metabolite of tamoxifen in human bile

1 reference

12 December 2020

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

2 references

12 December 2020

https://api.crossref.org/works/10.1038%2FCLPT.2011.32

7 January 2021

inferred from DOI database lookup

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

1 reference

12 December 2020

Identifiers

DOI

10.1038/CLPT.2011.32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

release_2w4wn4ke2nbehf47ybb7hizmta

26 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2w4wn4ke2nbehf47ybb7hizmta

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430657%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

21430657

1 reference